EPO and Alzheimer disease: Since EPO is effective in controlling various chronic inflammatory conditions by altering the metabolism of eicosanoid [31], the administration of EPO could be a beneficial in normalizing the altered epidermal eicosanoid metabolism in the lesional epidermal skin of AD patients [32].